Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

VALERIE DIANE ESPINOSA

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1649245697
CMS profile
120305
Location
AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$80.44

4 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $80.44 4

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $34.00 2
Medtronic, Inc. $24.31 1
Abbott Laboratories $22.13 1

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

VALERIE DIANE ESPINOSA

NPI 1649245697 · CMS profile ID 120305

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1649245697?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
VALERIE DIANE ESPINOSA, NPI 1649245697, CMS profile ID 120305. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1649245697?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). VALERIE DIANE ESPINOSA, NPI 1649245697, CMS profile ID 120305. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1649245697?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
VALERIE DIANE ESPINOSA, NPI 1649245697, CMS profile ID 120305, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1649245697?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

4 matching records · $80.44 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 4 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–4 of 4.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Amgen Inc. $18.4711/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1115606634 CMS
Abbott Laboratories $22.1305/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125168592 CMS
Medtronic, Inc. $24.3105/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119415358 CMS
Amgen Inc. $15.5303/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1115606628 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $16.77 1
PY2020 $2,295.00 1
PY2021 $180.01 9
PY2022 $102.32 6
PY2023 $158.18 9
PY2024 $80.44 4
PY2025 $190.15 9

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $6,754.50 7
PY2024 Principal investigator $16,033.58 16
PY2023 Principal investigator $23,025.89 42
PY2022 Recipient $4,540.00 1
PY2022 Principal investigator $427,933.76 272
PY2021 Principal investigator $331,661.14 458
PY2020 Principal investigator $107,369.32 113
PY2019 Principal investigator $258,474.85 102

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

113 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novo Nordisk AS $1,039.22 12/22/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422665
Principal investigator 1 Novo Nordisk AS $14.00 12/21/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 822166307
Principal investigator 1 Novo Nordisk AS $41.00 12/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 822166305
Principal investigator 1 Novo Nordisk AS $180.00 11/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422563
Principal investigator 1 Novo Nordisk AS $422.15 10/29/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422617
Principal investigator 1 Novo Nordisk AS $216.00 10/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422533
Principal investigator 1 Novo Nordisk AS $36.00 10/26/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422531
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,500.00 10/23/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY PA
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 737090885
Principal investigator 1 Novo Nordisk AS $23.06 10/15/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422535
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,200.00 10/14/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY PA
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 737090015
Principal investigator 1 Novo Nordisk AS $892.97 09/22/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422615
Principal investigator 1 Novo Nordisk AS $29,438.81 09/01/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4375 No dispute reported 06/30/2026 742422605
Principal investigator 1 Novo Nordisk AS $1,000.00 08/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4375 No dispute reported 06/30/2026 742422603
Principal investigator 1 Novo Nordisk AS $1,000.00 08/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4376 No dispute reported 06/30/2026 742422607
Principal investigator 1 Novo Nordisk AS $15,902.16 08/27/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4376 No dispute reported 06/30/2026 742422609
Principal investigator 1 Novo Nordisk AS $470.82 07/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422297
Principal investigator 1 Novo Nordisk AS $27.96 07/21/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422547
Principal investigator 1 Novo Nordisk AS $1,186.70 06/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4376 No dispute reported 06/30/2026 742422293
Principal investigator 1 Novo Nordisk AS $941.63 06/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422295
Principal investigator 1 Novo Nordisk AS $4.90 06/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422451
Principal investigator 1 Novo Nordisk AS $36.00 06/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422453
Principal investigator 1 Novo Nordisk AS $23.46 05/29/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422201
Principal investigator 1 Novo Nordisk AS $414.57 05/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421825
Principal investigator 1 Novo Nordisk AS $912.38 05/26/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4375 No dispute reported 06/30/2026 742421853
Principal investigator 1 Novo Nordisk AS $23.97 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422185
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422187
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422189
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422191
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422193
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422195
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422197
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422199
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422239
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422241
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422243
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422245
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422247
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422249
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422251
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422253
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422255
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422257
Principal investigator 1 Novo Nordisk AS $108.00 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422259
Principal investigator 1 Novo Nordisk AS $108.00 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422261
Principal investigator 1 Novo Nordisk AS $108.00 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422263
Principal investigator 1 Novo Nordisk AS $108.00 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422265
Principal investigator 1 Novo Nordisk AS $108.00 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422267
Principal investigator 1 Novo Nordisk AS $108.00 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422269
Principal investigator 1 Novo Nordisk AS $108.00 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422271
Principal investigator 1 Novo Nordisk AS $108.00 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422273
Principal investigator 1 Novo Nordisk AS $108.00 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422275
Principal investigator 1 Novo Nordisk AS $108.00 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422277
Principal investigator 1 Novo Nordisk AS $108.00 05/05/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422279
Principal investigator 1 Novo Nordisk AS $941.63 04/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421823
Principal investigator 1 Novo Nordisk AS $2,522.46 04/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4375 No dispute reported 06/30/2026 742421849
Principal investigator 1 Novo Nordisk AS $300.00 04/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4375 No dispute reported 06/30/2026 742421851
Principal investigator 1 Novo Nordisk AS $420.11 04/23/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4376 No dispute reported 06/30/2026 742421893
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,200.00 04/21/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY PA
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 737077667
Principal investigator 1 Novo Nordisk AS $63.00 03/26/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421819
Principal investigator 1 Novo Nordisk AS $3,526.87 03/26/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421821
Principal investigator 1 Novo Nordisk AS $7,112.30 03/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4375 No dispute reported 06/30/2026 742421845
Principal investigator 1 Novo Nordisk AS $175.48 03/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4375 No dispute reported 06/30/2026 742421847
Principal investigator 1 Novo Nordisk AS $1,335.24 03/24/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4376 No dispute reported 06/30/2026 742421891
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,500.00 03/12/2020 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY PA
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 737074029
Principal investigator 1 Novo Nordisk AS $14.97 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421907
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421909
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421911
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421913
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421915
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421917
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421919
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421921
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421923
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421925
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421927
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421929
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421931
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421933
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421935
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421937
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421939
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421941
Principal investigator 1 Novo Nordisk AS $1,778.35 02/25/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421817
Principal investigator 1 Novo Nordisk AS $7,466.30 02/25/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4375 No dispute reported 06/30/2026 742421843
Principal investigator 1 Novo Nordisk AS $80.00 02/11/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4375 No dispute reported 06/30/2026 742421841
Principal investigator 1 Novo Nordisk AS $2,690.15 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421813
Principal investigator 1 Novo Nordisk AS $1,275.00 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742421815
Principal investigator 1 Novo Nordisk AS $40.00 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4375 No dispute reported 06/30/2026 742421827
Principal investigator 1 Novo Nordisk AS $47.74 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4375 No dispute reported 06/30/2026 742421829
Principal investigator 1 Novo Nordisk AS $11,359.02 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4375 No dispute reported 06/30/2026 742421831
Principal investigator 1 Novo Nordisk AS $2,829.41 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9536-4376 No dispute reported 06/30/2026 742421887
Principal investigator 1 Novo Nordisk AS $10.60 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422001
Principal investigator 1 Novo Nordisk AS $10.60 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422003
Principal investigator 1 Novo Nordisk AS $10.60 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422005
Principal investigator 1 Novo Nordisk AS $10.60 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422007
Principal investigator 1 Novo Nordisk AS $10.60 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422009
Principal investigator 1 Novo Nordisk AS $10.60 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422011
Principal investigator 1 Novo Nordisk AS $10.60 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422013
Principal investigator 1 Novo Nordisk AS $10.60 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422015
Principal investigator 1 Novo Nordisk AS $10.60 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422017
Principal investigator 1 Novo Nordisk AS $10.60 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422019
Principal investigator 1 Novo Nordisk AS $10.60 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422021
Principal investigator 1 Novo Nordisk AS $2.68 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422023
Principal investigator 1 Novo Nordisk AS $216.00 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422025
Principal investigator 1 Novo Nordisk AS $216.00 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422027
Principal investigator 1 Novo Nordisk AS $216.00 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422029
Principal investigator 1 Novo Nordisk AS $216.00 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422031
Principal investigator 1 Novo Nordisk AS $216.00 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422033
Principal investigator 1 Novo Nordisk AS $216.00 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422035
Principal investigator 1 Novo Nordisk AS $216.00 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422037
Principal investigator 1 Novo Nordisk AS $216.00 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422039
Principal investigator 1 Novo Nordisk AS $216.00 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422041
Principal investigator 1 Novo Nordisk AS $216.00 01/28/2020 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 742422043